Oppenheimer expects S&P 500 to bounce back a little in April. The investment firm warns the bounce could prove short lived.

Tarsus Pharmaceuticals Inc. closed an upsized $134.8 million public offering this month.The Irvine-based biopharmaceutical ...

Technology stocks are not in an artificial-intelligence-induced bubble and attractive investment opportunities in the sector ...

The Goldman Sachs Group (NYSE:GS – Get Free Report) had its target price upped by investment analysts at JPMorgan Chase & Co.

U.S. investment banks are poised to cut more jobs if economic uncertainty continues to weigh on dealmaking in the months ...

Home improvement retailer Kingfisher became the latest British company to report a negative impact from U.K. Finance Minister ...

Oppenheimer kicked off coverage of Lam Research with a sparkling “outperform” rating and a $95 price target, sparking interest in the chipmaker. Other analysts also joined the cheer squad, with most ...

Goldman Sachs (GS) last week reduced its year-end target for the ... Deutsche Bank (DB), Wells Fargo (WFC) and Oppenheimer (OPY) all forecasting the index to finish the year at 7,000 or above. There ...

Oppenheimer downgraded shares of The Goldman Sachs Group (NYSE:GS – Free Report) from an outperform rating to a market ...

StubHub has applied to list its Class A common stock on the New York Stock Exchange ("NYSE") under the ticker symbol "STUB." J.P. Morgan and Goldman Sachs & Co. LLC will act as lead joint book-running ...

NKE Price Action: Nike stock is down 5.3% to $68.04 on Friday, hitting new 52-week lows of $65.17 earlier in the day's ...

European equity funds recorded the largest four-week inflows in nearly the past 10 years, with European stocks outperforming ...